Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001539497-25-002007
Filing Date
2025-08-04
Accepted
2025-08-04 08:00:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5179
  Complete submission text file 0001539497-25-002007.txt   6839
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Subject) CIK: 0001580063 (see all company filings)

EIN.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91551 | Film No.: 251178057
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1240 NEW HAVEN RD NAUGATUCK CT 06770-5000
Business Address
TAGGETT MARGARET ELLEN (Filed by) CIK: 0002079485 (see all company filings)

Type: SCHEDULE 13G